Cassava Sciences Inc (SAVA)

[biotechnician]

Here is some NICE math for PTIE;
8.8 million shares @ $1.15 + 8.8 million warrants to buy shares @ $1.25 leads to about 24 million outstanding shares for PTIE. That would raise 21 million in cash PLUS the 3 million + grant = 24 million in funds/cash as well. AXON for example with failure in ALzheimers has a Market cap of 250 million. So PTIE would need to trade at $10 for a MC of 250 million and their drug looks promising. The investors at $10.20 would make 9 dollars a share or 153 million in profit since they would be buying these 17 m shares at a avg cost of $1.20 including the warrants exercised. A $5 stock price would only be a 120 million market cap..This looks very inexpensive going into a MULTI BILLION dollar market in phase 2 this calendar year.